| SC 13G | 2014-02-04 | VANGUARD SPECIALIZED FUNDS | ALNYLAM PHARMACEUTICALS, INC. | 4,105,200 | 6.5% | EDGAR |
| SC 13G/A | 2014-01-28 | BlackRock Inc. | ALNYLAM PHARMACEUTICALS, INC. | 3,941,556 | 6.2% | EDGAR |
| SC 13G | 2013-12-10 | WELLINGTON MANAGEMENT CO LLP | ALNYLAM PHARMACEUTICALS, INC. | 7,680,876 | 12.1% | EDGAR |
| SC 13G/A | 2013-02-14 | FMR LLC | ALNYLAM PHARMACEUTICALS, INC. | 7,862,160 | 15.0% | EDGAR |
| SC 13G | 2013-02-14 | ALNYLAM PHARMACEUTICALS, INC. | Regulus Therapeutics Inc. | 6,150,500 | 17.2% | EDGAR |
| SC 13G/A | 2013-02-13 | Eastern Capital LTD | ALNYLAM PHARMACEUTICALS, INC. | 4,929,116 | 8.0% | EDGAR |
| SC 13G/A | 2013-02-11 | NOVARTIS AG | ALNYLAM PHARMACEUTICALS, INC. | 4,051,002 | 7.7% | EDGAR |
| SC 13G/A | 2013-02-06 | BlackRock Inc. | ALNYLAM PHARMACEUTICALS, INC. | 3,298,120 | 6.3% | EDGAR |
| SC 13G/A | 2012-02-14 | FMR LLC | ALNYLAM PHARMACEUTICALS, INC. | 4,796,976 | 11.2% | EDGAR |
| SC 13G/A | 2012-02-14 | Eastern Capital LTD | ALNYLAM PHARMACEUTICALS, INC. | 4,229,116 | 9.8% | EDGAR |
| SC 13G/A | 2012-02-13 | BlackRock Inc. | ALNYLAM PHARMACEUTICALS, INC. | 2,263,901 | 5.3% | EDGAR |
| SC 13G/A | 2011-02-14 | FMR LLC | ALNYLAM PHARMACEUTICALS, INC. | 5,800,765 | 13.7% | EDGAR |
| SC 13G/A | 2011-02-14 | Aletheia Research & Management, Inc. | ALNYLAM PHARMACEUTICALS, INC. | - | - | EDGAR |
| SC 13G/A | 2011-02-14 | Eastern Capital LTD | ALNYLAM PHARMACEUTICALS, INC. | 3,783,179 | 9.0% | EDGAR |
| SC 13G/A | 2011-02-07 | NOVARTIS AG | ALNYLAM PHARMACEUTICALS, INC. | 5,602,898 | 13.3% | EDGAR |
| SC 13G/A | 2011-02-03 | BlackRock Inc. | ALNYLAM PHARMACEUTICALS, INC. | 2,303,590 | 5.5% | EDGAR |
| SC 13G | 2010-06-04 | Eastern Capital LTD | ALNYLAM PHARMACEUTICALS, INC. | 2,502,520 | 6.0% | EDGAR |
| SC 13G/A | 2010-02-16 | FMR LLC | ALNYLAM PHARMACEUTICALS, INC. | 6,272,308 | 15.0% | EDGAR |
| SC 13G/A | 2010-02-16 | NOVARTIS AG | ALNYLAM PHARMACEUTICALS, INC. | 5,547,675 | 13.3% | EDGAR |
| SC 13G/A | 2010-02-16 | Aletheia Research & Management, Inc. | ALNYLAM PHARMACEUTICALS, INC. | 2,863,569 | 6.8% | EDGAR |